TENX Archived Articles
Tenax Therapeutics: Navigating the Path to Approval for Levosimendan in PH-HFpEF
Published on March 11, 2025
Tenax Therapeutics (NASDAQ:TENX): Advancing Cardiovascular Therapies with Innovative Approaches
Published on November 17, 2024